Australia's largest stock trading and investment forum Australia's #1 stock forum

CGB

Click for more information

0.00%

2.1¢ cann global limited

Ann: Preliminary Final Report, page-23

First 23 Last

Share
Profile

Follow
Ex Oyster farmer

543 Posts.

152

01/09/22

13:05

Post #: 63460915
Share

Originally posted by Christopher67: ↑

Hi Aussie, you are correct, they still have an agreement with Canntab. They are still on the hook for a further 900k of expenditure as well.
But the question remains - if these were selling well,, and they were unhappy with Medcan,, why did they not order any further pills prior to ending their agreement with Medcan on 5th July 2022?
The balance of the last order, was delivered 21st December 2021. Order more, or establish another partner with licenses, BEFORE cancelling your deal. Still no word on Releaf, no official announcement of a deal.

Expand

At a guess I’d say cgb are on the verge of announcing a complete take over of Medcan,that’s why the chest of over 9 million in monies has been sat idle waiting.
Craig from medcan was looking for investors awhile back and this might be cgb’s opportunity?

CGB Price at posting: 2.3¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BUX

Buxton projects new graphite province discovery at WA Narryer play

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 136 more messages in this thread...

First 23 Last

Add CGB (ASX) to my watchlist